Cargando…

利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型

OBJECTIVE: To establish a novel method to determine specific type of amyloidosis through laser microdissection and mass spectrometry (LMD/MS) based proteomic analysis. METHODS: There were 138 formalin-fixed and paraffin-embedded (FFPE) biopsy samples of patients who were diagnosed as systemic amyloi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342159/
https://www.ncbi.nlm.nih.gov/pubmed/25778882
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.003
_version_ 1783555389206298624
collection PubMed
description OBJECTIVE: To establish a novel method to determine specific type of amyloidosis through laser microdissection and mass spectrometry (LMD/MS) based proteomic analysis. METHODS: There were 138 formalin-fixed and paraffin-embedded (FFPE) biopsy samples of patients who were diagnosed as systemic amyloidosis used in this study. For each case, a 10 µm section stained with congored and positive amyloid deposits were identified under fluorescent light, followed by micro-dissection and mass spectrometry analysis. The amyloidosis subtype was confirmed based on the most abundant amyloid protein. RESULTS: The tissue types of 138 specimens were as following: subcutaneous abdominal fat accounted for 26%, tongue for 19%, gingiva for 11%, kidney for 9%, intestine for 9%, heart for 6% and others for 20%. Specific types of amyloid were accurately detected in 121 cases, including 106 (87.6%) amyloid light chain (AL) type, 7 (5.8%) amyloid trans-thy-retin (ATTR), 2 (1.7%) amyloidogenic protein A (AA), 2 (1.7%) amyloid heavy chain (AH)/AL+AH, 2 (1.7%) fibrinogen alpha chain (AFib), 1(0.8%) amyloid apolipoprotein A-type Ⅱ (AApoA-Ⅱ) and one (0.8%) amyloid lysozyme (ALys). Diagnosis of amyloidosis was excluded in 5 cases. The types of twelve cases were indeterminate by LMD/MS. On the whole, LMD/MS reached 91.3% accuracy rate in amyloid typing. Commonly involved organs (for example, heart, kidney and liver) turned out to be suitable sources of FFPE samples with typing success rate of almost 100%. In contrast, MS analysis was successful in only 83.3% of subcutaneous abdominal fat samples. CONCLUSION: LMD/MS method provided a more direct technique for accurate typing of amyloidosis in a single procedure.
format Online
Article
Text
id pubmed-7342159
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73421592020-07-16 利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To establish a novel method to determine specific type of amyloidosis through laser microdissection and mass spectrometry (LMD/MS) based proteomic analysis. METHODS: There were 138 formalin-fixed and paraffin-embedded (FFPE) biopsy samples of patients who were diagnosed as systemic amyloidosis used in this study. For each case, a 10 µm section stained with congored and positive amyloid deposits were identified under fluorescent light, followed by micro-dissection and mass spectrometry analysis. The amyloidosis subtype was confirmed based on the most abundant amyloid protein. RESULTS: The tissue types of 138 specimens were as following: subcutaneous abdominal fat accounted for 26%, tongue for 19%, gingiva for 11%, kidney for 9%, intestine for 9%, heart for 6% and others for 20%. Specific types of amyloid were accurately detected in 121 cases, including 106 (87.6%) amyloid light chain (AL) type, 7 (5.8%) amyloid trans-thy-retin (ATTR), 2 (1.7%) amyloidogenic protein A (AA), 2 (1.7%) amyloid heavy chain (AH)/AL+AH, 2 (1.7%) fibrinogen alpha chain (AFib), 1(0.8%) amyloid apolipoprotein A-type Ⅱ (AApoA-Ⅱ) and one (0.8%) amyloid lysozyme (ALys). Diagnosis of amyloidosis was excluded in 5 cases. The types of twelve cases were indeterminate by LMD/MS. On the whole, LMD/MS reached 91.3% accuracy rate in amyloid typing. Commonly involved organs (for example, heart, kidney and liver) turned out to be suitable sources of FFPE samples with typing success rate of almost 100%. In contrast, MS analysis was successful in only 83.3% of subcutaneous abdominal fat samples. CONCLUSION: LMD/MS method provided a more direct technique for accurate typing of amyloidosis in a single procedure. Editorial office of Chinese Journal of Hematology 2015-02 /pmc/articles/PMC7342159/ /pubmed/25778882 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.003 Text en 2015年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型
title 利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型
title_full 利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型
title_fullStr 利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型
title_full_unstemmed 利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型
title_short 利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型
title_sort 利用激光显微切割联合质谱蛋白质组学方法进行系统性淀粉样变性分型
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342159/
https://www.ncbi.nlm.nih.gov/pubmed/25778882
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.003
work_keys_str_mv AT lìyòngjīguāngxiǎnwēiqiègēliánhézhìpǔdànbáizhìzǔxuéfāngfǎjìnxíngxìtǒngxìngdiànfěnyàngbiànxìngfēnxíng
AT lìyòngjīguāngxiǎnwēiqiègēliánhézhìpǔdànbáizhìzǔxuéfāngfǎjìnxíngxìtǒngxìngdiànfěnyàngbiànxìngfēnxíng
AT lìyòngjīguāngxiǎnwēiqiègēliánhézhìpǔdànbáizhìzǔxuéfāngfǎjìnxíngxìtǒngxìngdiànfěnyàngbiànxìngfēnxíng
AT lìyòngjīguāngxiǎnwēiqiègēliánhézhìpǔdànbáizhìzǔxuéfāngfǎjìnxíngxìtǒngxìngdiànfěnyàngbiànxìngfēnxíng
AT lìyòngjīguāngxiǎnwēiqiègēliánhézhìpǔdànbáizhìzǔxuéfāngfǎjìnxíngxìtǒngxìngdiànfěnyàngbiànxìngfēnxíng
AT lìyòngjīguāngxiǎnwēiqiègēliánhézhìpǔdànbáizhìzǔxuéfāngfǎjìnxíngxìtǒngxìngdiànfěnyàngbiànxìngfēnxíng
AT lìyòngjīguāngxiǎnwēiqiègēliánhézhìpǔdànbáizhìzǔxuéfāngfǎjìnxíngxìtǒngxìngdiànfěnyàngbiànxìngfēnxíng
AT lìyòngjīguāngxiǎnwēiqiègēliánhézhìpǔdànbáizhìzǔxuéfāngfǎjìnxíngxìtǒngxìngdiànfěnyàngbiànxìngfēnxíng